A platform for collecting cancer tissue samples
PINCER (A Platform Study for solId orgaN CancERs); an Agile Regional Platform Study to Deliver High Quality Translational Research
This study is trying to gather cancer tissue samples from patients having surgery or biopsies to help with research on solid organ cancers.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Ages | 16 Years to 100 Years |
| Sex | All |
| Sponsor | University of Liverpool Academic / other |
| Locations | 1 site (Liverpool) |
| Trial ID | NCT05650125 on ClinicalTrials.gov |
What this trial studies
This observational study aims to create a comprehensive platform for the collection of biosamples from patients undergoing surgery or biopsy for solid organ cancers. It will facilitate the efficient gathering of both historical and fresh tissue samples, along with matched clinical and radiological data, to support various translational research projects. Researchers can propose specific sub-studies that will be reviewed and approved by the PINCER steering committee, ensuring alignment with the overarching protocol. The focus is on maximizing access to high-quality biosamples for cancer research without generating a biobank.
Who should consider this trial
Good fit: Ideal candidates for this study are adults undergoing biopsy or surgical resection for any solid organ cancer.
Not a fit: Patients who refuse or are unable to consent, as well as pediatric patients, will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly enhance the availability of high-quality biosamples for cancer research, leading to better understanding and treatment options for patients.
How similar studies have performed: Other studies utilizing similar biosampling platforms have shown success in enhancing cancer research, indicating that this approach is promising.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Biopsy or surgical resection as standard of care Exclusion Criteria: * Refusal or inability to consent, paediatric patients
Where this trial is running
Liverpool
- University of Liverpool — Liverpool, United Kingdom (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.